198 related articles for article (PubMed ID: 10886211)
1. Screening for mutations of Bcl10 in leukaemia.
Grimwade D; Du MQ; Langabeer S; Rogers J; Solomon E
Br J Haematol; 2000 Jun; 109(3):611-5. PubMed ID: 10886211
[TBL] [Abstract][Full Text] [Related]
2. Bcl10 in chronic lymphocytic leukaemia and T-cell prolymphocytic leukaemia.
Yuille MR; Stone JG; Bradshaw PS; Houlston RS
Br J Haematol; 1999 Nov; 107(2):384-5. PubMed ID: 10583229
[TBL] [Abstract][Full Text] [Related]
3. BCL10 deletions in haematological malignancies: a cloning artefact?
Duke V; Kapoor A; Gricks C; Melo J; Foroni L
Br J Haematol; 2000 Dec; 111(4):1106-8. PubMed ID: 11167747
[TBL] [Abstract][Full Text] [Related]
4. Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.
Takahashi H; Hosokawa Y; Suzuki R; Morishima Y; Nakamura S; Seto M
Jpn J Cancer Res; 1999 Dec; 90(12):1316-20. PubMed ID: 10665648
[TBL] [Abstract][Full Text] [Related]
5. BCL10 gene mutations rarely occur in lymphoid malignancies.
Luminari S; Intini D; Baldini L; Berti E; Bertoni F; Zucca E; Cro L; Maiolo AT; Cavalli F; Neri A
Leukemia; 2000 May; 14(5):905-8. PubMed ID: 10803524
[TBL] [Abstract][Full Text] [Related]
6. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
[TBL] [Abstract][Full Text] [Related]
7. Low frequency of BCL10 gene mutations in B-cell non-Hodgkin's lymphoma.
Tadokoro J; Nakamura Y; Furusawa S; Mitani K
Int J Hematol; 2001 Feb; 73(2):222-5. PubMed ID: 11372735
[TBL] [Abstract][Full Text] [Related]
8. Lack of BCL10 mRNA mutation in lymphold malignancies.
Kawano T; Iwase S; Nakayama R; Horiguchi-Yamada J; Kobayashi M; Yamada H
Anticancer Res; 2002; 22(1A):305-9. PubMed ID: 12017308
[TBL] [Abstract][Full Text] [Related]
9. Mutations of the BCL10 gene are not associated with the blast crisis of chronic myeloid leukaemia.
Bose S; Goldman JM; Melo JV
Leukemia; 1999 Nov; 13(11):1894-6. PubMed ID: 10557068
[No Abstract] [Full Text] [Related]
10. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
[TBL] [Abstract][Full Text] [Related]
11. Absence of Bcl10 gene mutations in Ewing's sarcomas.
Park YK; Chi SG; Unni KK
Oncol Rep; 2001; 8(6):1333-5. PubMed ID: 11605060
[TBL] [Abstract][Full Text] [Related]
12. BCL10 gene mutation in lymphoma.
Du MQ; Peng H; Liu H; Hamoudi RA; Diss TC; Willis TG; Ye H; Dogan A; Wotherspoon AC; Dyer MJ; Isaacson PG
Blood; 2000 Jun; 95(12):3885-90. PubMed ID: 10845924
[TBL] [Abstract][Full Text] [Related]
13. BCL10 somatic mutations rarely occur in gastric lymphoma: detection of high frequency of polymorphisms in BCL10 coding region.
Chen YW; Wong KY; Au WY; Liang RH; Srivastava G
Cancer Genet Cytogenet; 2001 Jun; 127(2):184-7. PubMed ID: 11425462
[TBL] [Abstract][Full Text] [Related]
14. Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in children.
Xu F; Taki T; Yang HW; Hanada R; Hongo T; Ohnishi H; Kobayashi M; Bessho F; Yanagisawa M; Hayashi Y
Br J Haematol; 1999 Apr; 105(1):155-62. PubMed ID: 10233379
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression of beta-catenin discriminates acute myeloid leukaemia from acute lymphoblastic leukaemia.
Serinsöz E; Neusch M; Büsche G; Wasielewski R; Kreipe H; Bock O
Br J Haematol; 2004 Aug; 126(3):313-9. PubMed ID: 15257703
[TBL] [Abstract][Full Text] [Related]
16. Lack of BCL10 mutations in Hodgkin's disease-derived cell lines.
Re D; Benenson E; Wolf J; Diehl V; Staratschek-Jox A
Br J Haematol; 2000 May; 109(2):420-2. PubMed ID: 10848834
[TBL] [Abstract][Full Text] [Related]
17. Methylenetetrahydrofolate reductase C677T genetic polymorphisms and risk of leukaemia among the North Indian population.
Hussain SR; Naqvi H; Raza ST; Ahmed F; Babu SG; Kumar A; Zaidi ZH; Mahdi F
Cancer Epidemiol; 2012 Aug; 36(4):e227-31. PubMed ID: 22441130
[TBL] [Abstract][Full Text] [Related]
18. BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma.
Bullinger L; Leupolt E; Schaffner C; Mertens D; Bentz M; Lichter P; Döhner H; Stilgenbauer S
Leukemia; 2000 Aug; 14(8):1490-2. PubMed ID: 10942247
[TBL] [Abstract][Full Text] [Related]
19. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
[TBL] [Abstract][Full Text] [Related]
20. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors.
Kakinuma H; Habuchi T; Ito T; Mishina M; Sato K; Satoh S; Akao T; Ogawa O; Kato T
Cancer Genet Cytogenet; 2001 Apr; 126(2):134-8. PubMed ID: 11376806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
